These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 28821440)
1. Apelin protects against liver X receptor-mediated steatosis through AMPK and PPARα in human and mouse hepatocytes. Huang J; Kang S; Park SJ; Im DS Cell Signal; 2017 Nov; 39():84-94. PubMed ID: 28821440 [TBL] [Abstract][Full Text] [Related]
2. Omega-3 polyunsaturated fatty acids protect human hepatoma cells from developing steatosis through FFA4 (GPR120). Kang S; Huang J; Lee BK; Jung YS; Im E; Koh JM; Im DS Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Feb; 1863(2):105-116. PubMed ID: 29126901 [TBL] [Abstract][Full Text] [Related]
3. 7 Huang J; Lee SJ; Kang S; Choi MH; Im DS J Pharmacol Exp Ther; 2020 Jul; 374(1):142-150. PubMed ID: 32341017 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of gomisin N against hepatic steatosis through AMPK activation. Yun YR; Kim JH; Kim JH; Jung MH Biochem Biophys Res Commun; 2017 Jan; 482(4):1095-1101. PubMed ID: 27914812 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis. Kim YW; Kim YM; Yang YM; Kim TH; Hwang SJ; Lee JR; Kim SC; Kim SG Free Radic Biol Med; 2010 Feb; 48(4):567-78. PubMed ID: 20005944 [TBL] [Abstract][Full Text] [Related]
6. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase. Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089 [TBL] [Abstract][Full Text] [Related]
7. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice. López-Oliva ME; Garcimartin A; Muñoz-Martínez E Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234 [TBL] [Abstract][Full Text] [Related]
8. Oleanolic Acid Inhibits Liver X Receptor Alpha and Pregnane X Receptor to Attenuate Ligand-Induced Lipogenesis. Lin YN; Chang HY; Wang CCN; Chu FY; Shen HY; Chen CJ; Lim YP J Agric Food Chem; 2018 Oct; 66(42):10964-10976. PubMed ID: 30351048 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction. Jin SH; Yang JH; Shin BY; Seo K; Shin SM; Cho IJ; Ki SH Toxicol Appl Pharmacol; 2013 Aug; 271(1):95-105. PubMed ID: 23651738 [TBL] [Abstract][Full Text] [Related]
10. Nectandrin B, a lignan isolated from nutmeg, inhibits liver X receptor-α-induced hepatic lipogenesis through AMP-activated protein kinase activation. Choi du G; Kim EK; Yang JW; Song JS; Kim YM Pharmazie; 2015 Nov; 70(11):733-9. PubMed ID: 26790190 [TBL] [Abstract][Full Text] [Related]
11. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1. Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133 [TBL] [Abstract][Full Text] [Related]
12. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling. Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331 [TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect. Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685 [TBL] [Abstract][Full Text] [Related]
14. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332 [TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE. Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317 [TBL] [Abstract][Full Text] [Related]
16. Fowl Adenovirus Serotype 4 Induces Hepatic Steatosis via Activation of Liver X Receptor-α. Yuan F; Hou L; Wei L; Quan R; Wang J; Liu H; Liu J J Virol; 2021 Feb; 95(6):. PubMed ID: 33361420 [TBL] [Abstract][Full Text] [Related]
17. AMP-activated protein kinase suppresses the expression of LXR/SREBP-1 signaling-induced ANGPTL8 in HepG2 cells. Lee J; Hong SW; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY Mol Cell Endocrinol; 2015 Oct; 414():148-55. PubMed ID: 26254015 [TBL] [Abstract][Full Text] [Related]
18. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes. Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057 [TBL] [Abstract][Full Text] [Related]
19. Deoxypodophyllotoxin in Anthriscus sylvestris alleviates fat accumulation in the liver via AMP-activated protein kinase, impeding SREBP-1c signal. Kim KY; Park KI; Lee SG; Baek SY; Lee EH; Kim SC; Kim SH; Park SG; Yu SN; Oh TW; Kim JH; Kim KJ; Ahn SC; Kim YW Chem Biol Interact; 2018 Oct; 294():151-157. PubMed ID: 30148990 [TBL] [Abstract][Full Text] [Related]
20. Apelin ameliorates TNF-α-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ. Chu J; Zhang H; Huang X; Lin Y; Shen T; Chen B; Man Y; Wang S; Li J PLoS One; 2013; 8(2):e57231. PubMed ID: 23437347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]